Edited by Yifan Peng, Rui Zhang and Hua Xu.
Volume 22 Supplement 3
Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors were not involved in the peer review of any supplement articles they have co-authored. No other competing interests were declared.
Virtual9 August 2021
Clinical trial protocols are the foundation for advancing medical sciences, however, the extraction of accurate and meaningful information from the original clinical trials is very challenging due to the compl...
Diabetic retinopathy (DR) is a leading cause of blindness in American adults. If detected, DR can be treated to prevent further damage causing blindness. There is an increasing interest in developing artificia...
Citation Impact
Journal Impact Factor: 3.8 (2024)
5-year Journal Impact Factor: 4.4 (2024)
Source Normalized Impact per Paper (SNIP): 1.461 (2024)
SCImago Journal Rank (SJR): 1.041 (2024)
Speed
Submission to first editorial decision (median days): 9
Submission to acceptance (median days): 217
Usage 2024
Downloads: 3,248,174
Altmetric mentions: 1,208
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication